Literature DB >> 1345865

Treatment strategies for Alzheimer's disease.

D M Bowen, P T Francis, M N Pangalos, P H Stephens, A W Procter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1345865     DOI： 10.1016/0140-6736(92)91050-i

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study.

Authors:  Sharon M Castellino; Janet A Tooze; Lynn Flowers; Debbie F Hill; Kevin P McMullen; Edward G Shaw; Susan K Parsons
Journal:  Pediatr Blood Cancer       Date:  2012-01-11       Impact factor: 3.167

2.  NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist.

Authors:  S N Dijk; P T Francis; G C Stratmann; D M Bowen
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

3.  5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task.

Authors:  B J Cole; G H Jones; J D Turner
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

Review 4.  Disease-modifying drugs in Alzheimer's disease.

Authors:  Laura Ghezzi; Elio Scarpini; Daniela Galimberti
Journal:  Drug Des Devel Ther       Date:  2013-12-06       Impact factor: 4.162

5.  Landscape of immune infiltration in entorhinal cortex of patients with Alzheimer's disease.

Authors:  Hui Zhang; Silu Cao; Yaru Xu; Xiaoru Sun; Miaomiao Fei; Qi Jing; Xiaodong Xu; Jinxuan Tang; Bing Niu; Cheng Li
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.